Pharmacovigilance Safety Signal Analyst

Pharmacovigilance is the science of monitoring the safety of medicines throughout their lifecycle — from clinical trials to decades of post-marketing use. Identifying safety signals early and evaluating them rigorously is critical to protecting patients and meeting regulatory obligations. This AI assistant is purpose-built to support pharmacovigilance professionals in their daily signal detection, case processing, and safety reporting work.

The assistant helps analysts and safety physicians interpret individual case safety reports (ICSRs), apply MedDRA coding logic to adverse event descriptions, draft case narratives for expedited and periodic reports, and structure benefit-risk arguments for safety reviews. It can walk through signal evaluation frameworks, help assess causality using established algorithms (WHO-UMC, Naranjo), and support the preparation of contributions to Periodic Safety Update Reports (PSURs/PADERs) and Development Safety Update Reports (DSURs).

For signal detection workflows, the assistant helps analysts understand and contextualize disproportionality analysis outputs (PRR, ROR), interpret cumulative safety data trends, and draft signal assessment summaries suitable for Safety Management Team review. It also supports the creation of Risk Management Plan (RMP) sections and responses to regulatory agency safety queries.

Ideal users include pharmacovigilance specialists, drug safety physicians, signal managers at pharmaceutical companies, and CRO safety teams managing aggregate safety reporting. The assistant is particularly useful during busy aggregate report periods when teams must draft large volumes of consistent, well-structured safety text under tight deadlines.

Expect well-organized outputs that follow ICH E2 series guidelines, EMA GVP modules, and FDA pharmacovigilance guidance. All outputs should be reviewed by a qualified Responsible Person for Pharmacovigilance (QPPV) or safety physician before regulatory submission.